Evidence map›Paper›PMID 31481653›Full record

ArticleCell death & disease2019

Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer.

Weihong Niu, Yanwei Luo, Xinye Wang, Yao Zhou, Hui Li, Heran Wang, Yaojie Fu, Shanshan Liu, Shanghelin Yin, Jianglei Li and 10 more

RetractedOpen access · goldAbstract readRetraction Notice
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 4 countries.

Weihong NiuThe Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Yanwei LuoThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Xinye WangThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Yao ZhouThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Hui LiThe Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Heran WangThe Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Yaojie FuMedical school of Xiangya, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Shanshan LiuMedical school of Xiangya, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Shanghelin YinMedical school of Xiangya, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Jianglei LiMedical school of Xiangya, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Ran ZhaoThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Yukun LiuThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Songqing FanThe Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China.
Zheng LiThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Wei XiongThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Xiaoling LiThe Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Guiyuan LiThe Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, 410013, People's Republic of China.
Caiping RenCancer Research Institute, Central South University, Changsha, Hunan, 410078, People's Republic of China.
Ming TanMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA. mtan@health.southalabama.edu.ORCID http://orcid.org/0000-0003-2007-9898
Ming ZhouThe Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, 410013, People's Republic of China. zhouming2001@163.com.
Central South University · CNUSA Mitchell Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31481653
PMCPMC6722080
OpenAlexW2972301755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.